|
Vista has
established a strategic relationship with Charles Lieber’s lab at
Harvard University, as well as with ICX MesoSystems, Tokyo Electron, and
UNM Neurosurgery. The importance and nature of these relationships is
described below. As these alliances involve resources and risks on the
part of our partners, they offer the potential for significant reward
in the way of stock issued against staged contributions and of enhanced
future revenues. Vista and its collaborators are also pursuing grants
based on our continuous biomarker measurement systems.
|
|
|
|
Professor Charles Lieber, of the Harvard Chemistry Department, is
widely held as the foremost pioneer in the development of nanowires
and applications thereof. He is the patented inventor of most of
the core technologies that enable nanowires and was the co-founder
of Nanosys, Inc, one of the world’s leading nanotechnology
companies. He is Head of Vista’s Scientific Board. Harvard
University itself has committed to Vista, contributing substantial
IP and research resources.
MesoSystems/ICX,
is the world’s largest design-engineering-manufacturer of
continuous monitoring devices for weapons and bio-terror agents.
MesoSystems has deep expertise in designing/integrating devices
substantially more complex than Vista’s Nanobiosensor. MesoSystems
will manufacture/assemble Vista’s Nanobiosensor device in
its Albuquerque facilities. In addition to the benefits of a strategic
partnership with MesoSystems for engineering and manufacturing purposes,
MesoSystems’ expertise also accrues to Vista by way of the
fact that Dr. Charles Call, a Ph.D in Mechanical Engineering and
CEO of MesoSystems, has joined Vista’s Scientific Advisory
Board. Working closely with Dr. Call and other key personnel at
MesoSystems, Vista already has prototypes ready, and they are undergoing
internal alpha testing. Vista will install early systems at Harvard
and MesoSystems for final optimization and to verify inter-system
variability. It will also conduct several critical experiments,
the results of which will be published to increase market awareness. |
|
|
|
|
|
Tokyo Electron Limited is a leading global supplier of semiconductor
production equipment, and engages in development, manufacturing,
and sales in a wide range of product fields. Tokyo Electron provides
highly respected products and services to customers through a
global network of approximately 90 locations in 15 countries in
the U.S., Europe, and Asia. In addition to providing financing
to Vista, Tokyo Electron also gives Vista a high-powered manufacturing
and marketing capability.
The
Department of Neurosurgery at the University of New Mexico provides
high quality neurosurgical care to its patients, rigorously trains
its resident physicians, and engages in laboratory and clinical
research. Dr. Chris Taylor, who serves as Vista's Chief Medical
Officer, is a Professor of Neurosurgery at UNM Medical School.
The clinical and medical advantages that accrue to Vista via this
relationship speak for themselves.
|
|
|